Medication-induced electrolyte imbalances: a call for increased awareness and vigilance
DOI:
https://doi.org/10.18203/2320-6012.ijrms20261371Keywords:
Electrolyte imbalance, Diuretics, Cardiovascular drugs, Chemotherapy agents, Corticosteroids, NSAIDs and electrolyte managementAbstract
Electrolyte imbalances are a significant concern in clinical practice, often caused by medications such as diuretics, cardiovascular drugs, chemotherapy agents, and antibiotics. These imbalances can lead to serious complications, including cardiac arrhythmias and increased mortality. Key electrolytes like sodium, potassium, calcium, and magnesium play crucial roles in maintaining fluid balance, nerve function, and muscle contraction. Medications can disrupt electrolyte balance, causing hyponatremia, hyperkalemia, hypomagnesemia, and other imbalances. Risk factors include pre-existing kidney disease, heart failure, and concomitant use of multiple medications. Treatment involves discontinuing the causative medication, correcting electrolyte imbalances, and managing underlying conditions. This review analyzes drug induced electrolyte disorders, their consequences, and treatment options. Understanding the mechanisms of drug-induced electrolyte imbalances can help clinicians manage complex cases and provide effective care.
References
Holland K. All about electrolyte imbalance. Healthline. 2022. Available at: https://www.healthline.com/health/electrolyte-disorders. Accessed on 15 February 2026.
Shrimanker I, Bhattarai S. Electrolytes. StatPearls-NCBI Bookshelf. 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK541123/. Accessed on 15 February 2026.
Wikipedia contributors. Electrolyte imbalance. Wikipedia. Available at: https://en.wikipedia.org/w/index.php?title=Electrolyte_imbalance&oldid=1301319477. Accessed on 15 February 2026.
Brass EP, Thompson WL. Drug-induced electrolyte abnormalities. Drugs. 1982;24(3):207-28.
Thomas L. Medication-related electrolyte imbalances in ICUs: Challenges and nursing strategies. Int J Adv Res Med Surg Nurs. 2025;7(1):296-8.
Michael DK, Imad FB, Gordon S. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health-System Pharmacy. 2005;62(16):1663-82.
Shrimanker I, Bhattarai S. Electrolytes. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2025. Available at: https://www.ncbi.nlm.nih.gov/books/NBK541123/. Accessed on 15 February 2026.
Ayhan YE, İlerler EE, Sosyal D, Bektay MY, Karakurt S, Daşkaya H, et al. Assessment of drug-induced electrolyte disorders in intensive care units: a multicenter observational study. Front Med. 2024;11:1343483.
Salem CB, Badreddine A, Fathallah N, Slim R, Hmouda H. Drug-Induced hyperkalemia. Drug Safety. 2014;37(9):677-92.
Verzicco I, Regolisti G, Quaini F, Bocchi P, Brusasco I, Ferrari M, et al. Electrolyte disorders induced by antineoplastic drugs. Front Oncol. 2020;10:779.
Liamis G, Milionis H, Elisaf M. A review of Drug-Induced Hyponatremia. Am J Kidney Dis. 2008;52(1):144-53.
Gröber U. Magnesium and drugs. Int J Molecular Sci. 2019;20(9):2094.
Veltri KT, Mason C. Medication-Induced hypokalemia. 2015. Available at: https://share.google/T7NM2x42oyfwOmqM6. Accessed on 15 February 2026.
Huxel C, Raja A, Ollivierre-Lawrence MD. Loop diuretics. StatPearls-NCBI Bookshelf. 2023. Available https://www.ncbi.nlm.nih.gov/books/NBK546656/. Accessed on 15 February 2026.
Melby JC. Selected mechanisms of diuretic-induced electrolyte changes. Am J Cardiol. 1986;58(2):A1-4.
Arumugham VB, Shahin MH. Therapeutic uses of diuretic agents. StatPearls-NCBI Bookshelf. 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK557838/. Accessed on 15 February 2026.
Mayer G. Effects of diuretic therapy on electrolyte and acid-base homeostasis. Wien Med Wochenschr. 1996;146(16):436-8.
Egom EE, Chirico D, Clark AL. A review of thiazide-induced hyponatraemia. Clin Med (Lond). 2011;11(5):448-51.
Hwang KS, Kim G. Thiazide-Induced hyponatremia. Electrolytes Blood Pressure. 2010;8(1):51.
Clayton JA, Rodgers S, Blakey J, Avery A, Hall IP. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Brit J Clin Pharmacol. 2005;61(1):87-95.
Mann SJ. The silent epidemic of Thiazide‐Induced Hyponatremia. J Clin Hypert. 2008;10(6):477-84.
Egom EEA, Chirico D, Clark AL. A review of thiazide-induced hyponatraemia. Clin Med. 2011;11(5):448-51.
Olivero JJ. Cardiac consequences of electrolyte imbalance. Methodist DeBakey Cardiovasc J. 2016;12(2):125-6.
Arumugham VB, Shahin MH. Therapeutic uses of diuretic agents. StatPearls-NCBI Bookshelf. 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK557838/. Accessed on 15 February 2026.
Gill MB. Potassium Wasting vs Potassium Sparing Diuretics. Power. 2023. Available at: https://www.withpower.com/guides/potassium-wasting-vs-potassium-sparing-diuretics-8a6a. Accessed on 15 February 2026.
Potassium sparing diuretics. Avaible at: https://www.osmosis.org/learn/Potassium_sparing%20diuretics. Accessed on 15 February 2026.
Wikipedia contributors. Potassium-sparing diuretic. Wikipedia. 2025. Available at: https://en.wikipedia.org/wiki/Potassium-sparing_diuretic#References. Accessed on 15 February 2026.
Urso C, Brucculeri S, Caimi G. Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Failure Rev. 2015;20(4):493-503.
Fhadil S, Wright P. Electrolytes in cardiology. Pharmaceut J. 2015;294(7849):181-4.
Olivero JJ. Cardiac consequences of electrolyte imbalance. Methodist DeBakey Cardiovascular J. 201612(2):125-6.
Polderman KH, Girbes AR. Severe electrolyte disorders following cardiac surgery: a prospective controlled observational study. Crit Care. 2004;8(6):R459-66.
Zoccali C, Levin A, Mallamaci F, Giugliano R, De Caterina R. Advanced chronic kidney disease coexisting with heart failure: navigating patients’ management. Clin Kidney J. 2025;18(5):sfaf128.
Hunter RW, Bailey MA. Hyperkalemia: pathophysiology, risk factors and consequences. Nephrol Dialysis Transplantat. 2019;34(3):iii2-iii11.
Verzicco I, Regolisti G, Quaini F, Bocchi P, Brusasco I, Ferrari M, et al. Electrolyte disorders induced by antineoplastic drugs. Front Oncol. 2020;10.
Oronsky B, Caroen S, Oronsky A, Dobalian VE, Oronsky N, Lybeck M, et al. Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management. Cancer Chemoth Pharmacol. 2017;80(5):895-907.
Kalali D. Potassium imbalances induced by systemic cancer therapy: pathophysiology and potential therapeutic strategies. Oncol Clin Pract. 2023;20(1):22-6.
Rodriguez M, Solanki DL, Whang R. Refractory potassium repletion due to cisplatin-induced magnesium depletion. Arch Intern Med. 1989;149(11):2592-4.
Gangireddy M, Patel P, Nookala V. Ifosfamide. StatPearls-NCBI Bookshelf. 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK542169/. Accessed on 15 January 2026.
Martinez D, Rodelo J, García SP. Ifosfamide as a cause of Fanconi syndrome. Cureus. 2022;14(3):e22755.
Leem AY, Kim HS, Yoo BW, Kang BD, Kim MH, Rha SY, Kim HS. Ifosfamide-induced Fanconi syndrome with diabetes insipidus. Kor J Internal Med. 2014;29(2):246.
Febvey-Combes O, Guitton J, Marec-Berard P, Faure-Conter C, Blanc E, Chabaud S, et al. Renal toxicity of ifosfamide in children with cancer: an exploratory study integrating aldehyde dehydrogenase enzymatic activity data and a wide-array urinary metabolomics approach. BMC Pediatr. 2024;24(1):196.
Joseph SW, Grant KE, Sousou JM, Qadir N, Reddy P. Severe hyponatremia caused by Sertraline-Induced Syndrome of inappropriate antidiuretic hormone secretion: a complication with critical implications for patient safety. Cureus. 2024;16(10):e71309.
Jacob S, Spinier SA. Hyponatremia Associated with Selective Serotonin-Reuptake Inhibitors in Older Adults. Ann Pharmacotherapy. 2006;40(9):1618-22.
Edinoff AN, Akuly HA, Hanna TA, Ochoa CO, Patti SJ, Ghaffar YA, et al. Selective serotonin reuptake inhibitors and Adverse Effects: A Narrative review. Neurol Int. 2021;13(3):387-401.
Kabi A, Kaeley N, Bhatia R, Mohanty A. Carbamazepine-induced hyponatremia-A wakeup call. J Family Med Prim Care. 2019;8(5):1786.
Prakash S, Bhatia PS, Raheja SG, Pawar M. Carbamazepine-induced hyponatremia. Brit J Anaesth. 2016;117:el_13266.
Seifert J, Letmaier M, Greiner T, Schneider M, Deest M, Eberlein CK, et al. Psychotropic drug-induced hyponatremia: results from a drug surveillance program–an update. J Neural Transmission. 2021;128(8):1249-64.
Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia Associated with Carbamazepine and Oxcarbazepine Therapy: A Review. Epilepsia. 1994;35(1):181-8.
Downloads
Published
How to Cite
Issue
Section
